Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Revenue: 2011-2024

Historic Revenue for Veracyte (VCYT) over the last 14 years, with Dec 2024 value amounting to $445.8 million.

  • Veracyte's Revenue rose 13.82% to $131.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $495.1 million, marking a year-over-year increase of 16.41%. This contributed to the annual value of $445.8 million for FY2024, which is 23.46% up from last year.
  • Latest data reveals that Veracyte reported Revenue of $445.8 million as of FY2024, which was up 23.46% from $361.1 million recorded in FY2023.
  • Veracyte's 5-year Revenue high stood at $445.8 million for FY2024, and its period low was $117.5 million during FY2020.
  • For the 3-year period, Veracyte's Revenue averaged around $367.8 million, with its median value being $361.1 million (2023).
  • As far as peak fluctuations go, Veracyte's Revenue declined by 2.40% in 2020, and later spiked by 86.85% in 2021.
  • Over the past 5 years, Veracyte's Revenue (Yearly) stood at $117.5 million in 2020, then skyrocketed by 86.85% to $219.5 million in 2021, then skyrocketed by 35.09% to $296.5 million in 2022, then climbed by 21.76% to $361.1 million in 2023, then climbed by 23.46% to $445.8 million in 2024.